,:

Lachlan F Miles1, Erica M Wood2

  • 1Department of Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia; Department of Anaesthesia, Austin Health, Heidelberg, VIC, Australia.

PubMed
概括

与实验室结果相比,诸如HemoCue®,i-STATTM和Rad-67TM之类的临床血红蛋白测试设备显示出可变性. HemoCue®证明了引导不适当的红细胞输血的风险最低.